Fitt Insider cover image

328. Kat Cole, CEO of AG1

Fitt Insider

00:00

Trial rigor and scale of studies

Kat discusses double/triple-blind trials, participant counts, partnerships with UC Davis and $30M research commitments.

Play episode from 25:51
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app